Status:
RECRUITING
SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Karolinska Institutet
Conditions:
Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Rupture
Eligibility:
All Genders
16-40 years
Phase:
NA
Brief Summary
Randomized control trial comparing two different Anterior Cruciate Ligament (ACL) grafts in Anterior Cruciate Ligament Reconstruction: the semitendinosus hamstrings graft and the quadriceps graft. Cap...
Detailed Description
The purpose of the study is to evaluate the quadriceps graft with bone-plug in Anterior Cruciate Ligament Reconstruction (ACL-R) and compare it with the most common choice of graft, semitendinosus ham...
Eligibility Criteria
Inclusion
- Pre-injury Tegner Activity Scale≥7
- Intended return to sports to prior sport and Tegner Activity Scale Level
- Time between injury and inclusion not more than 6 months
- MR verified ACL rupture
Exclusion
- Previous knee injury with symptoms before ACL injury
- Neurological disease, inflammatory disease, connective tissue disease or balance disorder
- Previous lower limb fracture or surgery
- Laxity in the medial collateral ligament (MCL) and lateral collateral ligament (LCL) \> grade 1
- PCL rupture or Multiligament knee injury (MLKI)
- Radiographic sign of osteoarthritis (OA)
- Previous knee surgery or ligament injury in contralateral knee
- Beighton score ≥ 5
Key Trial Info
Start Date :
February 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2035
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04295148
Start Date
February 10 2020
End Date
May 31 2035
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capio Artro Clinic AB
Stockholm, Stockholm County, Sweden, 11428